Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
The Journal of Infectious Diseases
|
July 9, 2010
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine
Peter Gilbert, Maggie Wang, Terri Wrin, et al.
Plos Pathogens
|
July 3, 2013
HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1
Tomer Hertz, Hasan Ahmed, David P Friedrich, et al.
Journal of Immunological Methods
|
October 5, 2011
Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells
Christopher A Todd, Kelli M Greene, Xuesong Yu, et al.
Plos One
|
November 19, 2014
Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge
Angela K Talley, Sara A Healy, Olivia C Finney, et al.
Vaccine Insights
|
April 24, 2023
The quest for vaccine-induced immune correlates of protection against tuberculosis
Elisa Nemes, Andrew Fiore-Gartland, Cesar Boggiano, et al.
Open Forum Infectious Diseases
|
December 16, 2024
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial
Dean Follmann, Xiaowei Wang, Lindsey R Baden, et al.
Scientific Reports
|
February 23, 2022
Author Correction: Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk
Lue Ping Zhao, Pavitra Roychoudhury, Peter Gilbert, et al.
Scientific Reports
|
January 25, 2022
Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk
Lue Ping Zhao, Pavitra Roychoudhury, Peter Gilbert, et al.
Journal of Virology
|
July 30, 2005
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
Ming Li, Feng Gao, John R Mascola, et al.
Msphere
|
January 31, 2020
Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
Zanele Ditse, Nonhlanhla N Mkhize, Michael Yin, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
The Journal of Infectious Diseases
|
July 9, 2010
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine
Peter Gilbert, Maggie Wang, Terri Wrin, et al.
Plos Pathogens
|
July 3, 2013
HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1
Tomer Hertz, Hasan Ahmed, David P Friedrich, et al.
Journal of Immunological Methods
|
October 5, 2011
Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells
Christopher A Todd, Kelli M Greene, Xuesong Yu, et al.
Plos One
|
November 19, 2014
Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge
Angela K Talley, Sara A Healy, Olivia C Finney, et al.
Vaccine Insights
|
April 24, 2023
The quest for vaccine-induced immune correlates of protection against tuberculosis
Elisa Nemes, Andrew Fiore-Gartland, Cesar Boggiano, et al.
Open Forum Infectious Diseases
|
December 16, 2024
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial
Dean Follmann, Xiaowei Wang, Lindsey R Baden, et al.
Scientific Reports
|
February 23, 2022
Author Correction: Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk
Lue Ping Zhao, Pavitra Roychoudhury, Peter Gilbert, et al.
Scientific Reports
|
January 25, 2022
Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk
Lue Ping Zhao, Pavitra Roychoudhury, Peter Gilbert, et al.
Journal of Virology
|
July 30, 2005
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
Ming Li, Feng Gao, John R Mascola, et al.
Msphere
|
January 31, 2020
Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
Zanele Ditse, Nonhlanhla N Mkhize, Michael Yin, et al.
Page
of 10